The PerkinElmer COVID-19 Antigen Test is a CE marked in vitro diagnostic device for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens. The lateral flow immunoassay test can be used to screen or aid in the diagnosis of COVID-19 in asymptomatic or symptomatic individuals. A positive or negative result can be obtained as early as 15 minutes to facilitate immediate isolation or treatment decisions.
The test is ideally suited for point-of-care (POC) clinical and non-clinical settings such as healthcare centers, travel hubs, businesses and educational institutions. Clinical studies in symptomatic and asymptomatic populations, including individuals with low viral load, have shown sensitivity >97% amongst all samples. Specificity of the test across 202 negative samples was 100%, which means no false positives were identified.
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.